Soma Pharmaceuticals' Retatrutide: A Promising Weight Therapy Approach? June 28, 2026 Category: Blog Retatrutide, developed by Soma Chems , is attracting increasing attention as a innovative method for obesity control . This dual-action drug integrates the activity of a GLP-1 receptor agonist and a GIP receptor stimulant, more in read more